1,4-naphthoquinone has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bezerra, ECA; Burbano, RMR; da Rocha, DR; da Silva, EL; de Moraes, MEA; de Sousa Portilho, AJ; Ferreira, V; Montenegro, RC; Moraes Rego Gomes, CBS; Moreira-Nunes, CA | 1 |
1 other study(ies) available for 1,4-naphthoquinone and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
1,4-Naphthoquinone (CNN1) Induces Apoptosis through DNA Damage and Promotes Upregulation of
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; DNA Damage; Drug Resistance, Neoplasm; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukocytes, Mononuclear; Naphthoquinones; Up-Regulation | 2022 |